The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia

Autoimmunity

Volumn 47, Issue 8, 2014, Pages 519-529

  Zhang, Donglei ^a   Li, Huiyuan ^a   Ma, Li ^a   Zhang, Xian ^a   Xue, Feng ^a   Zhou, Zeping ^a,b   Chi, Ying ^a   Liu, Xiaofan ^a   Huang, Yueting ^a   Yang, Yanhui ^a,c   Yang, Renchi ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Autoimmune; Immunomodulation; Mesenchymal stem cell; Primary immune thrombocytopenia; Regulatory T cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DAMAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPHENOTYPING; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; COCULTURE; FLOW CYTOMETRY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; MESENCHYMAL STROMA CELL; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84912115339     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.938320     Document Type: Article

References (56)

1. Lai, R. C., T. S. Chen, and S. K. Lim. 2011. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen. Med. 6: 481-492
2. Owen, M. 1988. Marrow stromal stem cells. J. Cell Sci. Suppl. 10: 63-76
3. Almeida-Porada, G., C. D. Porada, N. Tran, and E. D. Zanjani. 2000. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 95: 3620-3627
4. Nasef, A., A. Chapel, C. Mazurier, et al. 2007. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr. 13: 217-226
5. Di Nicola, M., C. Carlo-Stella, M. Magni, et al. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843
6. Klyushnenkova, E., J. D. Mosca, V. Zernetkina, et al. 2005. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12: 47-57
7. Uccelli, A., L. Moretta, and V. Pistoia. 2006. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 36: 2566-2573
8. Duffy, M. M., T. Ritter, R. Ceredig, and M. D. Griffin. 2011. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res. Ther. 2: 34
9. Aggarwal, S., and M. F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822
10. English, K., J. M. Ryan, L. Tobin, et al. 2009. Cell contact, prostaglandin E2 and transforming growth factor beta 1 play nonredundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells. Clin. Exp. Immunol. 156: 149-160
11. Tasso, R., C. Ilengo, R. Quarto, et al. 2012. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Investig. Ophthalmol. Vis. Sci. 53: 786-793
12. Stasi, R. 2012. Immune thrombocytopenia: pathophysiologic and clinical update. Semin. Thromb. Hemost. 38: 454-462
13. Semple, J. W., D. Provan, M. B. Garvey, and J. Freedman. 2010. Recent progress in understanding the pathogenesis of immune thrombocytopenia. Curr. Opin. Hematol. 17: 590-595
14. Mouzaki, A., M. Theodoropoulou, I. Gianakopoulos, et al. 2002. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood 100: 1774-1779
15. Liu, B., H. Zhao, M. C. Poon, et al. 2007. Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura. Eur. J. Haematol. 78: 139-143
16. Nishimoto, T., and M. Kuwana. 2013. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin. Hematol. 50: S43-S49
17. Perez-Simon, J. A., S. Tabera, M. E. Sarasquete, et al. 2009. Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura. Cytotherapy 11: 698-705
18. Provan, D., R. Stasi, A. C. Newland, et al. 2010. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115: 168-186
19. Sun, L. Y., H. Y. Zhang, X. B. Feng, et al. 2007. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 16: 121-128
20. Nie, Y., C. Lau, A. Lie, et al. 2010. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 19: 850-859
21. Larghero, J., D. Farge, A. Braccini, et al. 2008. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann. Rheum. Dis. 67: 443-449
22. Glennie, S., I. Soeiro, P. J. Dyson, et al. 2005. Bone marrow mesenchymal stem cells induce division arrest energy of activated T cells. Blood 105: 2821-2827
23. Mohanty, S. T., L. Kottam, A. Gambardella, et al. 2010. Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res. Ther. 12: R149
24. Uccelli, A., G Mancardi, and S. Chiesa. 2008. Is there a role for mesenchymal stem cells in autoimmune diseases? Autoimmunity 41: 592-595
25. Chen, X. T., S. T. Chan, H. Hosseini, et al. 2011. Transplantation of retrovirally transduced bone marrow prevents autoimmune disease in aged mice by peripheral tolerance mechanisms. Autoimmunity 44: 384-393
26. Volarevic, V., A. Al-Qahtani, N. Arsenijevic, et al. 2010. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 43: 255-263
27. Ma, J., Y. N. Ning, M. Xu, et al. 2013. Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia. Blood 122: 2074-2082
28. Solchaga, L. A., K. Penick, J. D. Porter, et al. 2005. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell. Physiol. 203: 398-409
29. Tamama, K., V. H. Fan, L. G. Griffith, et al. 2006. Epidermal growth factor as a candidate for ex vivo expansion of bone marrowderived mesenchymal stem cells. Stem Cells 24: 686-695
30. Fang, B., Y. Song, Q. Lin, et al. 2007. Human adipose tissuederived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatr. Transplant. 11: 814-817
31. Vishnubalaji, R., M. Al-Nbaheen, B. Kadalmani, et al. 2012. Comparative investigation of the differentiation capability of bonemarrow-And adipose-derived mesenchymal stem cells by qualitative and quantitative analysis. Cell Tissue Res. 347: 419-427
32. Eppley, B. L., J. E. Woodell, and J. Higgins. 2004. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plastic Reconstr. Surg. 114: 1502-1508
33. Alsousou, J., M. Thompson, P. Hulley, et al. 2009. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J. Bone Joint Surg. Br. 91: 987-996
34. Dimitriou, H., E. Linardakis, G. Martimianaki, et al. 2008. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy 10: 125-133
35. Pittenger, M. F., A. M. Mackay, S. C. Beck, et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
36. Prockop, D. J. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74
37. Carvalho, J. F., M. Blank, and Y. Shoenfeld. 2007. Vascular endothelial growth factor (VEGF) in autoimmune diseases. J. Clin. Immunol. 27: 246-256
38. van der Voort, R., T. E. Taher, R. M. Keehnen, et al. 1997. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J. Exp. Med. 185: 2121-2131
39. Kurz, S. M., S. S. Diebold, T. Hieronymus, et al. 2002. The impact of c-met/scatter factor receptor on dendritic cell migration. Eur. J. Immunol. 32: 1832-1838
40. Futamatsu, H., J. Suzuki, S. Mizuno, et al. 2005. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 96: 823-830
41. Okunishi, K., M. Dohi, K. Nakagome, et al. 2005. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175: 4745-4753
42. Benkhoucha, M., M. L. Santiago-Raber, G. Schneiter, et al. 2010. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 107: 6424-6429
43. Skibinski, G. 2003. The role of hepatocyte growth factor/c-met interactions in the immune system. Arch. Immunol. Ther. Exp. 51: 277-282
44. Krampera, M., A. Pasini, A. Rigo, et al. 2005. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106: 59-66
45. Kastrinaki, M. C., P. Sidiropoulos, S. Roche, et al. 2008. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann. Rheum. Dis. 67: 741-749
46. Bocelli-Tyndall, C., L. Bracci, G. Spagnoli, et al. 2007. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-And allogeneic-stimulated lymphocytes in vitro. Rheumatology 46: 403-408
47. Semple, J. W., Y. Milev, D. Cosgrave, et al. 1996. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 87: 4245-4254
48. Ogawara, H., H. Handa, K. Morita, et al. 2003. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur. J. Haematol. 71: 283-288
49. Panitsas, F. P., M. Theodoropoulou, A. Kouraklis, et al. 2004. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 103: 2645-2647
50. Xu, R., Z. Zheng, Y. Ma, et al. 2014. Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia. Exp. Ther. Med. 7: 149-154
51. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081-2095
52. OGarra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10: 801-805
53. Roncarolo, M. G., S. Gregori, M. Battaglia, et al. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50
54. Di Ianni, M., B. Del Papa, M. De Ioanni, et al. 2008. Mesenchymal cells recruit and regulate T regulatory cells. Exp. Hematol. 36: 309-318
55. Maccario, R., M. Podesta, A. Moretta, et al. 2005. Interaction of human mesenchymal stem cells with cells involved in alloantigenspecific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90: 516-525
56. Prevosto, C., M. Zancolli, P. Canevali, et al. 2007. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92: 881-888